Hepatocyte transplantation followed by auxiliary liver transplantation - A novel treatment for ornithine transcarbamylase deficiency

American Journal of Transplantation

Volumn 8, Issue 2, 2008, Pages 452-457

  Puppi, J ^a   Tan, N ^a   Mitry, R R ^a   Hughes, R D ^a   Lehec, S ^a   Mieli Vergani, G ^a   Karani, J ^a   Champion, M P ^b   Heaton, N ^a   Mohamed, R ^a   Dhawan, A ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

APOLT; Auxiliary liver transplantation; Hepatocyte transplantation; Metabolic disorders; Urea cycle

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; AMMONIA BLOOD LEVEL; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; FEMALE; FETUS; GRAFT REJECTION; HEPATOCYTE TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER ATROPHY; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN INTAKE; PSYCHOMOTOR DEVELOPMENT; UREA BLOOD LEVEL;

ADOLESCENT; FEMALE; HEPATOCYTES; HUMANS; INFANT, NEWBORN; LIVER TRANSPLANTATION; MALE; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; PREGNANCY; PRENATAL DIAGNOSIS; TREATMENT OUTCOME;

EID: 38149087576     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.02058.x     Document Type: Article

References (20)

1. Uchino T, Endo F, Matsuda I. Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. J Inherit Metab Dis 1998 21 (Suppl 1 151 159.
2. Batshaw ML, Brusilow S, Waber L et al. Treatment of inborn errors of urea synthesis: Activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med 1982 306 : 1387 1392.
3. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. N Engl J Med 1984 310 : 1500 1505.
4. Maestri NE, Clissold D, Brusilow SW. Neonatal onset ornithine transcarbamylase deficiency: A retrospective analysis. J Pediatr 1999 134 : 268 272.
5. Nicolaides P, Liebsch D, Dale N, Leonard J, Surtees R. Neurological outcome of patients with ornithine carbamoyltransferase deficiency. Arch Dis Child 2002 86 : 54 56.
6. Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: A retrospective evaluation. Eur J Pediatr 2003 162 : 410 416.
7. Maestri NE, Hauser ER, Bartholomew D, Brusilow SW. Prospective treatment of urea cycle disorders. J Pediatr 1991 119 : 923 928.
8. McBride KL, Miller G, Carter S, Karpen S, Goss J, Lee B. Developmental outcomes with early orthotopic liver transplantation for infants with neonatal-onset urea cycle defects and a female patient with late-onset ornithine transcarbamylase deficiency. Pediatrics 2004 114 : e523-e526.
9. Morioka D, Kasahara M, Takada Y et al. Current role of liver transplantation for the treatment of urea cycle disorders: A review of the worldwide English literature and 13 cases at Kyoto University. Liver Transpl 2005 11 : 1332 1342.
10. Horslen SP, McCowan TC, Goertzen TC et al. Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 2003 111 (6 Pt 1 1262 1267.
11. Stephenne X, Najimi M, Smets F, Reding R, de Ville de Goyet J, Sokal EM. Cryopreserved liver cell transplantation controls ornithine transcarbamylase deficient patient while awaiting liver transplantation. Am J Transplant 2005 5 : 2058 2061.
12. Mitry RR, Hughes RD, Aw MM et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant 2003 12 : 69 74.
13. Diener B, Utesch D, Beer N, Durk H, Oesch F. A method for the cryopreservation of liver parenchymal cells for studies of xenobiotics. Cryobiology 1993 30 : 116 127.
14. Fisher RA, Bu D, Thompson M, Wolfe L, Ritter JK. Optimization of conditions for clinical human hepatocyte infusion. Cell Transplant 2004 13 : 677 689.
15. Gallardo D, Rodriguez-Luaces M, Arostegui JI et al. Follow-up of chimerism status after allogeneic HLA-mismatched stem cell transplantation by detection of non-shared HLA alleles. Haematologica 2000 85 : 848 854.
16. Mas VR, Maluf DG, Thompson M, Ferreira-Gonzalez A, Fisher RA. Engraftment measurement in human liver tissue after liver cell transplantation by short tandem repeats analysis. Cell Transplant 2004 13 : 231 236.
17. Whitington PF, Alonso EM, Boyle JT et al. Liver transplantation for the treatment of urea cycle disorders. J Inherit Metab Dis 1998 21 (Suppl 1 112 118.
18. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990 212 : 368 375 discussion 75-77.
19. Uemoto S, Yabe S, Inomata Y et al. Coexistence of a graft with the preserved native liver in auxiliary partial orthotopic liver transplantation from a living donor for ornithine transcarbamylase deficiency. Transplantation 1997 63 : 1026 1028.
20. Kasahara M, Takada Y, Kozaki K et al. Functional portal flow competition after auxiliary partial orthotopic living donor liver transplantation in noncirrhotic metabolic liver disease. J Pediatr Surg 2004 39 : 1138 1141.